TITAN PHARMACEUTICAL INC (TTNP) Dividend History

Titan Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing innovative treatments for chronic diseases, particularly in the areas of neuroscience and addiction medicine. The company is known for its proprietary drug delivery technology and its lead product candidate, Probuphine, which is designed to provide long-term treatment for opioid dependence. Titan aims to improve patient outcomes through targeted therapies and sustained-release formulations.

400 Oyster Point Blvd, San Francisco, CA, 94080
Phone: (650) 244-4990
Website:

Dividend History

TITAN PHARMACEUTICAL INC currently does not pay dividends

Company News

  • U.S. stock futures rose on Monday as the selling pressure in the market appears to be exhausting. Investors assessed upbeat bank earnings and cooler-than-expected inflation data. The Commerce Secretary indicated that the electronics tariff exemptions are temporary, and further tariffs could follow soon.

    Benzinga
    Featured Companies: AMD AON AVGO GS JPM MS MTB NVDA PNFP PNFPP QQQ SPY SYNA
  • Halper Sadeh LLC is investigating potential violations of federal securities laws and/or breaches of fiduciary duties to shareholders related to the proposed mergers/acquisitions of Iteris, Titan Pharmaceuticals, and Forza X1.

    GlobeNewswire Inc.
  • Halper Sadeh LLC, an investor rights law firm, is investigating the proposed sales of Bally's Corporation, Kellanova, and Titan Pharmaceuticals, Inc. to assess potential violations of federal securities laws and breaches of fiduciary duties to shareholders.

    GlobeNewswire Inc.
    Featured Companies: BALY K
  • Shares of Agenus Inc. (NASDAQ: AGEN) fell sharply during Monday’s session. Agenus disclosed a 1-for-20 reverse stock split of common stock. Agenus Inc. (NASDAQ: AGEN) declined 17% to $0.4181 on Monday. Here are some other stocks moving in today's mid-day session. Gainers Auddia Inc. (NASDAQ: AUUD) shares jumped 231.7% to $4.72 after the company announced the USPTO awarded it with U.S. Patent 11,935,520 for the core AI technology the company uses in its flagship faidr app to deliver ad-free AM/FM radio stations to paid subscribers. Longeveron Inc. (NASDAQ: LGVN) shares climbed 93.2% to $4.2499 after the company submitted paperwork for a share offering. UTime Limited (NASDAQ: WTO) gained 56.8% to $0.29 after the company completed a private placement. U Power Limited (NASDAQ: UCAR) climbed 48% to $6.96 after the company announced announced that its battery-swapping and sharing model for two-wheeled and light four-wheeled electric vehicles is poised for a formal commercial rollout in Wuhu, Anhui Province, China. Arrowroot Acquisition Corp. (NASDAQ: ARRW) rose 38.2% to $19.53. Destiny Tech100 Inc. (NASDAQ: DXYZ) jumped 33.8% to $79.30 after jumping around 77% on Friday. TechPrecision Corporation (NASDAQ: TPCS) rose 29.8% to $4.2837 after the company announced the termination of the agreement to acquire Votaw Precision Technologies. Adlai Nortye Ltd. (NASDAQ: ANL) gained 27.9% to $10.68. Connexa Sports Technologies Inc. (NASDAQ: CNXA) surged 26.8% to $0.3801. AXT, Inc. (NASDAQ: AXTI) rose 25.7% to $3.9089. AXT said it sees preliminary revenue of $22.4 million to $22.7 million for the first quarter. Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) climbed 24.4% to $8.70. Apartment Income REIT Corp. (NYSE: AIRC) gained 22.6% to $38.47. Blackstone Real Estate will take AIR Communities private for approximately $10 billion. GD Culture Group Limited (NASDAQ: GDC) rose 22% to $1.1195. Outset Medical, Inc. ...

    Benzinga
  • SOUTH SAN FRANCISCO, Calif., Jan. 25, 2024 (GLOBE NEWSWIRE) -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) (“Titan” or the “Company”) today announced that by letter dated January 24, 2024, the Company was notified by The Nasdaq Stock Market LLC that the Company has regained compliance with the minimum $1.00 bid price requirement and otherwise satisfies all applicable criteria for continued listing on The Nasdaq Capital Market. As such, the listing matter has been closed.

    GlobeNewswire Inc.
Dividend data last updated 06/07/2025 05:17:09 UTC